Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
作者信息
Backeljauw Philippe
机构信息
Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Division of Endocrinology, University of Cincinnati College of Medicine Cincinnati, Ohio, USA.
出版信息
Pediatr Endocrinol Rev. 2008 Apr;5 Suppl 3:853-6.
PMID:18438329
Abstract
摘要
Zotero 插件